ArticleJournal of central nervous system disease2022

Oral Cladribine in Patients who Change From First-Line Disease Modifying Treatments for Multiple Sclerosis: Protocol of a Prospective Effectiveness and Safety Study (CLAD CROSS).

Georgios Tsivgoulis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.